37% yield increase: Almost all monetary gains from Indian GMO mustard will go to farmers, not to seed companies

Screen Shot at PM
Photo by Biswarup Ganguly/Wikimedia

Huge gains from biotech cotton commercialized [in India] two decades back notwithstanding, policymaking came to a standstill in terms of approving new biotech applications in agriculture, which negatively affects research, product releases, and productivity growth. The logjam in the issuance of regulatory approvals causes huge financial losses through foregone yield gains, ameliorating poverty, malnutrition and hidden hunger.

The government’s decision to move ahead on the much-delayed genetically modified mustard developed by the University of Delhi signifies a turnaround and bodes well for the country’s food system. Numerous tests over the last 20 years prove its safety for food, feed, and the environment in the Indian context. The resultant hybrid DMH-11 gives a yield advantage of 37% with the same level of inputs.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

The debate on GM mustard is confined mostly to newspaper columns and opinions, though it has occasionally spilled over into academic journals too. On its part, the National Academy of Agricultural Sciences, New Delhi discussed it and resolved [in 2017] that GM mustard is safe.

Our analysis shows that the farming community will get 99% of the additional monetary gains, leaving only 1% to the seed companies. Establishing a hybrid seed production system through this approval is a breakthrough, and several new hybrids with higher yields and desirable characteristics might follow in the next few years that can lead to a turnaround in mustard production.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-15-at-1.55.27-PM
America's trust in Trump-Kennedy's CDC health recommendations is plunging
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
ChatGPT-Image-Jun-24-2026-11_36_47-AM
Why the human genome is less a script than a puzzle
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
Screenshot 2026-06-25 at 10.55
Leading OB-GYN group challenges RFK, Jr. gutting of maternal vaccine schedule
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy's nutrition prescription for medical schools: Real problem, bad cure
Screenshot-2026-06-25-at-1.48.40-PM
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
Screenshot-2026-06-24-at-2.57.41-PM
Viewpoint: Trump’s Reflecting Pool algae fiasco points to a bigger culprit: Climate change
Screenshot-2026-06-24-at-2.40.46-PM
Hegseth reversal: As Air Force flu outbreak continues to surge, military reinstitutes mandatory vaccines for recruits
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.